Virtu Financial’s aTyr Pharma ATYR Stock Holding History

Virtu Financial’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28K	Buy	46,921 +6,873	+17%	+$4.49K	﹤0.01%	1307
2026 Q1	$31K	Sell	40,048 -38,905	-49%	-$32.8K	﹤0.01%	1352
2025 Q4	$62K	Buy	+78,953	New	+$64.8K	﹤0.01%	1279
2025 Q3	–	Sell	-31,959	Closed	-$162K	–	2210
2025 Q2	$162K	Buy	+31,959	New	+$126K	0.01%	961
2024 Q4	–	Sell	-29,017	Closed	-$51K	–	2178
2024 Q3	$51K	Buy	29,017 +1,051	+4%	+$1.91K	﹤0.01%	1009
2024 Q2	$44K	Buy	+27,966	New	+$48.7K	﹤0.01%	922
2024 Q1	–	Sell	-26,409	Closed	-$37K	–	2209
2023 Q4	$37K	Buy	26,409 +12,747	+93%	+$16.4K	﹤0.01%	1225
2023 Q3	$22K	Buy	+13,662	New	+$25.3K	﹤0.01%	1001
2022 Q3	–	Sell	-12,845	Closed	-$36K	–	2316
2022 Q2	$36K	Sell	12,845 -281	-2%	-$1.02K	﹤0.01%	1207
2022 Q1	$70K	Buy	+13,126	New	+$74.4K	0.01%	1052
2021 Q4	–	Sell	-143,677	Closed	-$1.3M	–	2259
2021 Q3	$1.3M	Buy	+143,677	New	+$859K	0.11%	168
2021 Q1	–	Sell	-27,736	Closed	-$108K	–	2109
2020 Q4	$108K	Buy	+27,736	New	+$101K	0.01%	1036
2019 Q4	$47K	Buy	+11,183	New	+$43.2K	﹤0.01%	1212
2019 Q2	–	Sell	-2,962	Closed	-$23K	–	1943
2019 Q1	$23K	Buy	+2,962	New	+$21.1K	﹤0.01%	1276
2018 Q3	–	Sell	-761	Closed	-$10K	–	2311
2018 Q2	$10K	Buy	+761	New	+$18K	﹤0.01%	1906

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's ATYR Position: Q2 2026 in Review

Virtu Financial increased its aTyr Pharma (ATYR) stake by 17% in Q2 2026, buying an estimated $4.49K and bringing the position to 46,921 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Virtu Financial first reported a position in ATYR in Q2 2018 and has held it in 15 quarters since. The position peaked at $1.3M in Q3 2021. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Virtu Financial held 46,921 shares of aTyr Pharma worth $28K as of Q2 2026.
Virtu Financial bought 6,873 aTyr Pharma shares in Q2 2026, an estimated $4.49K.
aTyr Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1307 holding.
Virtu Financial first reported a position in aTyr Pharma in Q2 2018 and has held it in 15 quarters since.
Virtu Financial's aTyr Pharma position peaked at $1.3M in Q3 2021.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.